| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Pharmacology and 2 Pharmacy, University of Sydney, New South Wales 2006, Australia
The increase in the amount of airway smooth muscle in the bronchial wall associated with asthma is partly due to hyperplasia. It is therefore important to determine which factors regulate growth and especially proliferation. In this study, we describe the effect of interleukin-4 (IL-4), a mast cell- and T lymphocyte-derived cytokine, on human airway smooth muscle proliferation as determined by [3H]thymidine uptake in the presence of fetal bovine serum (FBS), platelet-derived growth factor, basic fibroblast growth factor, and thrombin. IL-4 (5, 15, 50, and 150 ng/ml) significantly decreased 10% FBS-induced proliferation by 50, 73, 43, and 46%, respectively. The proliferative responses to platelet-derived growth factor (20 and 40 ng/ml), basic fibroblast growth factor (30 ng/ml), and thrombin (1 and 10 U/ml) were significantly reduced by 19, 21, 37, 36, and 57% respectively in the presence of 50 ng/ml of IL-4. We investigated the effect of IL-4 and other known inhibitors of smooth muscle proliferation, namely PGE2, heparin, and forskolin, on intracellular cAMP concentrations. IL-4 (50 ng/ml) and heparin (100 U/ml) did not alter intracellular cAMP levels when cells were treated with 1 or 10% FBS. PGE2 (1 µM) and forskolin (10 µM) significantly increased cAMP concentration above the control value in nonproliferating cells (1% FBS treated) by 7- and 37-fold, respectively. The effect of IL-4 (50 ng/ml), PGE2 (1 µM), and forskolin (10 µM) on cyclin D1 protein expression in 10% FBS-stimulated human airway smooth muscle cells was also examined. PGE2 and forskolin did not significantly inhibit cyclin D1 expression. However, IL-4 decreased cyclin D1 expression by 21%. These results provide evidence that IL-4 decreases human airway smooth muscle cell proliferation via a mechanism that is cAMP independent and mediated, in part, by a decrease in cyclin D1 protein expression.
hyperplasia; growth; inhibition; platelet-derived growth factor
This article has been cited by other articles:
|
|
 |
|
  G. Martin, R. J. O'Connell, A. Z. Pietrzykowski, S. N. Treistman, M. F. Ethier, and J. M. Madison Interleukin-4 activates large-conductance, calcium-activated potassium (BKCa) channels in human airway smooth muscle cells Exp Physiol, July 1, 2008; 93(7): 908 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Xie, M. B. Sukkar, R. Issa, U. Oltmanns, A. G. Nicholson, and K. F. Chung Regulation of TGF-{beta}1-induced connective tissue growth factor expression in airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L68 - L76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lalor, B. Truong, S. Henness, A. E. Blake, Q. Ge, A. J. Ammit, C. L. Armour, and J. M. Hughes Mechanisms of serum potentiation of GM-CSF production by human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1007 - L1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Chambers, J. L. Black, Q. Ge, S. M. Carlin, W. W. Au, M. Poniris, J. Thompson, P. R. Johnson, and J. K. Burgess PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L619 - L627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Carlin, M. Roth, and J. L. Black Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1020 - L1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Burgess, P. R. A. Johnson, Q. Ge, W. W. Au, M. H. Poniris, B. E. McParland, G. King, M. Roth, and J. L. Black Expression of Connective Tissue Growth Factor in Asthmatic Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hirst, M. P. Hallsworth, Q. Peng, and T. H. Lee Selective Induction of Eotaxin Release by Interleukin-13 or Interleukin-4 in Human Airway Smooth Muscle Cells Is Synergistic with Interleukin-1beta and Is Mediated by the Interleukin-4 Receptor alpha -Chain Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1161 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Page, A. J. Ammit, J. L. Black, and C. L. Armour Human mast cell and airway smooth muscle cell interactions: implications for asthma Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Chambers, J. L. Black, P. Poronnik, and P. R. A. Johnson Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1369 - L1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Madison and M. F. Ethier Interleukin-4 Rapidly Inhibits Calcium Transients in Response to Carbachol in Bovine Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 239 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. A. JOHNSON, M. ROTH, M. TAMM, M. HUGHES, Q. GE, G. KING, J. K. BURGESS, and J. L. BLACK Airway Smooth Muscle Cell Proliferation Is Increased in Asthma Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 474 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. LAPORTE, P. E. MOORE, S. BARALDO, M.-H. JOUVIN, T. L. CHURCH, I. N. SCHWARTZMAN, R. A. PANETTIERI Jr, J.-P. KINET, S. A. SHORE, and S. A. SHORE Direct Effects of Interleukin-13 on Signaling Pathways for Physiological Responses in Cultured Human Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 141 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Lee, P. R. A. Johnson, M. Roth, N. H. Hunt, and J. L. Black ERK activation and mitogenesis in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L1019 - L1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nakata, O. Kaminuma, K. Ogawa, H. Fujimura, K. Fushimi, H. Kikkawa, K. Naito, K. Ikezawa, R. W. Egan, and A. Mori Correlation between eosinophilia induced by CD4+ T cells and bronchial hyper-responsiveness Int. Immunol., March 1, 2001; 13(3): 329 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Carlin, P. Poronnik, D. I. Cook, L. Carpenter, T. J. Biden, P. R. A. Johnson, and J. L. Black An Antisense of Protein Kinase C-zeta Inhibits Proliferation of Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 555 - 559. [Abstract] [Full Text]
|
|
|
|
|
|
J. SOLWAY What Makes the Airways Contract Abnormally? Is It Inflammation? Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S164 - 167. [Full Text] [PDF]
|
|
|
|
|
|
S. Johnson and A. Knox Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1109 - L1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Hamad, S. R. Johnson, and A. J. Knox Antiproliferative effects of NO and ANP in cultured human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L910 - L918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Moore, T. L. Church, D. D. Chism, R. A. Panettieri Jr., and S. A. Shore IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L847 - L853. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
